m




M
M

 

 ‘


Ranbaxy is the India's largest pharmaceutical company,
Incorporated in ×
× eadquarters Located in
Gurgaon, aryana, India

he company went public in × , and Japanese

company Daiichi Sankyo gained majority control in 

Worldwide Presence
Ground presence in 
countries, products sold in over × countries
anufacturing locations in  countries

is currently Ranbaxy 
 and   , having

taken over from     in  
 istory of Ranbaxy
Ranbaxy was started by Ranbir Singh and Gurbax Singh
in ×
 as a distributor for a Japanese company Shionog i

he name Ranbaxy is a portmanteau word from the names of

its first owners bir and Gur


hai ohan Singh bought the company in ×

and after

that ohan Singh and Shivinder ohan Singh and after
that the company emerged to the Japanese company
Daiichi Sankyo in June 
£

 £
 ission

o become a Research-based International

Pharmaceutical Company

ÑM


Achieve significant business

in proprietary prescription products by 2012
with a strong presence in developed markets
 EF 
À  &

@
&

5


,
&&
  value c
 
  
 
 

Achieving customer satisfaction is fundamental of business

Provide products and services of the highest quality

Ensure profitable growth and enhance wealth of the

shareholders

Foster mutually beneficial relations with all our business

partners

anage our operations with high concern for safety and

Environment

e a responsible corporate citizen

 RanbaxyRanbaxy
ȂDaiichi Sankyo Partnership
ȂDaiichi Sankyo Partnership

Provides solutions to key need-gaps for each

organization

Strategic combination creates an Innovator and

Generic Pharmaceutical Powerhouse

Financially & strategically beneficial for all

stakeholders
Corporate Social Responsibility
£




 

An essential component of Ranbaxy's CSR is
to care for the community

ased on the theme Dz ealth For All setup

Ranbaxy Rural Development
rust dzin × 

ºperates in the states of Punjab, aryana,

P,Pand Delhi /Gurgaon to provide
integrated health care to about  people
staying in 100 villages and urban slum areasǥ
 Chairman, CEº & D

Dr
sutomu Une Chairman alvinder ohan Singh CEº &  D

 oard of Directors

oard of Directors

Dr
sutomu Une r
akashi Shoda r Atul Sobti

Chairman
r Rajesh V
Non Executive & CEº & D
Non Executive & Non Independent Shah
Non Independent Director Independent
Director Director

Dr Anthony  Wild r Rajesh V Shah

Independent Director
r Percy Shroff
Independent Director Independent Director
 Ranbaxyǯs
op Products
Simvastatin
£        


AmoxiClav Potassium

    ! ! "

Isotretinoin
!  !" 

Ciprofloxacin
#!$
ºmeprazole
 !
 Global Sales Split

CIS Asia

North
America
RºW

API
Europe

Global Sales ü : US $ ×× n

 arket Share of Ranbaxy
Global arkets ix 2008

 

he Company is currently ranked nd in the Indian

pharmaceutical market with   market share (IS, 

 

Global sales in  were USD ××  ü  ×

De-growth of  over previous year In Rupee terms, sales
grew moderately by × Sales during the Quarter recorded
growth of  at USD  ü  
 Emerging
markets accounted for  of sales during the year, while
developed markets contributed  
·
 

Glaxo Smith Kline

RPG Enterprises
East India Pharmaceutical

Dr Reddyǯs Laboratories

Cipla Ltd
Dabur India ltd
 Ranbaxy Laboratories Limited
Corporate Office
m


Gurgaon ××(Haryana), INDIA
Ph: × × ×
Fax: ××××
Web site:-wwwranbaxycom
w